A medication used to treat high blood pressure by blocking angiotensin II receptors, thereby relaxing blood vessels and reducing the risk of cardiovascular complications.

Indications:
- Treatment of essential hypertension in adults and children, and adolescents aged 6 to less than 18 years.

Main Active Ingredient:
- Olmesartan Medoxomil 20 mg per film-coated tablet.

Precautions:
- Use caution in patients with kidney or liver impairment, heart failure, or on sodium-restricted diets.
- Not recommended during pregnancy due to risk of fetal toxicity; discontinue promptly if pregnancy is detected.

Side Effects:
- Dizziness, headache, fatigue, diarrhea, back pain, respiratory symptoms (e.g., bronchitis, URTI).
- Rare but serious: hyperkalemia, reduced kidney function, allergic reactions.

Drug–Drug Interactions:
- Avoid co-administration with aliskiren in patients with diabetes.
- Use caution when combining with potassium-sparing diuretics, NSAIDs, lithium, certain other antihypertensives, or potassium supplements. (Interaction specifics can vary by product formulation and patient condition.)

- Take with or without food, usually once daily, preferably at the same time each day.
- Initial dose: 10 mg daily in adults; titrate up to 20 or 40 mg as needed.
- In children (6 to <18 years): start at 10 mg once daily; adjust up to 20 mg as needed, with a maximum of 20 mg when under 35 kg.

• Anti-hypertensive
• Heart Health

Olmesartan medoxomil, Microcrystalline Cellulose, Lactose Monohydrate, Hydroxypropylcellulose, Low-substituted Hydroxypropylcellulose, Magnesium Stearate; Film coating: Hypromellose, Lactose, Macrogol, Titanium Dioxide (E171)